Nevertheless, our current knowledge regarding the roles of distinct myeloid cell subsets in tumor progression and the effect of LAIR1 on M2-like MΦ functions and response to therapeutic drugs remains limited. The gene discussed is LAIR1; the disease is neoplasm.